Join us for this Launch Event to explore the latest insights on fixed-duration treatments in CLL with second-generation BTK inhibitors. Experts will present new AMPLIFY data, discuss its integration into updated guidelines like Onkopedia, and provide practical guidance on applying these findings to first-line CLL treatment.

Register for the upcoming Launch Webinar powered by healthbook

Monday, November 24^th, 2025
from 18:00 – 19:00 CET

FFHS Gleisarena
Zollstrasse 17
8005 Zurich

Please use entrance G17 in the Langbau building. The event with the floor and room number will be signposted in the entrance area.

Chair

Prof. Dr Davide Rossi
IOSI Bellinzona

Speakers

Prof. Dr Davide Rossi
IOSI Bellinzona

Prof. Dr Thorsten Zenz
USZ, Zurich

Dr Young-Lan Song
Stadtspital Triemli, Zurich

Agenda

18:00 – 18:05	Welcome & Introduction	Davide Rossi
18:05 – 18:20	What’s new in 1L CLL – the AMPLIFY study data	Davide Rossi
18:20 – 18:35	From Guidelines to Practice: Integrating AMPLIFY into the New Onkopedia Guidelines	Thorsten Zenz
18:35 – 18:55	From Data to Patients: Applying AMPLIFY in 1L CLL Treatment	Young-Lan Song
18:55 – 19:00	Closing Remarks	Davide Rossi